Identification of an Apolipoprotein A-I Structural Element That Mediates Cellular Cholesterol Efflux and Stabilizes ATP Binding Cassette Transporter A1*
暂无分享,去创建一个
P. Natarajan | T. Forte | J. Oram | M. Phillips | J. Bielicki | B. Chu
[1] B. Brewer,et al. Phosphorylation and Stabilization of ATP Binding Cassette Transporter A1 by Synthetic Amphiphilic Helical Peptides* , 2004, Journal of Biological Chemistry.
[2] M. Freeman,et al. ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux Published, JLR Papers in Press, November 16, 2003. DOI 10.1194/jlr.M300355-JLR200 , 2004, Journal of Lipid Research.
[3] M. Freeman,et al. Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1. , 2004, Biochemistry.
[4] A. Vaughan,et al. Phospholipid Transfer Protein Interacts with and Stabilizes ATP-binding Cassette Transporter A1 and Enhances Cholesterol Efflux from Cells* , 2003, Journal of Biological Chemistry.
[5] A. Tall,et al. Phosphorylation of a Pest Sequence in ABCA1 Promotes Calpain Degradation and Is Reversed by ApoA-I* , 2003, Journal of Biological Chemistry.
[6] A. Tall,et al. Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[7] P. Holvoet,et al. Domain Structure and Lipid Interaction in Human Apolipoproteins A-I and E, a General Model* , 2003, Journal of Biological Chemistry.
[8] O. Francone,et al. ATVB In Focus Role of ABCA1 in Cellular Cholesterol Efflux and Reverse Cholesterol Transport , 2003 .
[9] H. Brewer,et al. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200475-JLR200 , 2003, Journal of Lipid Research.
[10] A. von Eckardstein,et al. The Central Helices of ApoA-I Can Promote ATP-binding Cassette Transporter A1 (ABCA1)-mediated Lipid Efflux , 2003, The Journal of Biological Chemistry.
[11] P. Linsel-Nitschke,et al. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. , 2003, The Journal of clinical investigation.
[12] S. Witting,et al. The Role of Apolipoprotein A-I Helix 10 in Apolipoprotein-mediated Cholesterol Efflux via the ATP-binding Cassette Transporter ABCA1* , 2002, The Journal of Biological Chemistry.
[13] P. Natarajan,et al. Thiol-bearing synthetic peptides retain the antioxidant activity of apolipoproteinA-I(Milano). , 2002, Biochemical and biophysical research communications.
[14] B. McManus,et al. Increased ABCA1 activity protects against atherosclerosis. , 2002, The Journal of clinical investigation.
[15] S. Yokoyama,et al. Helical Apolipoproteins Stabilize ATP-binding Cassette Transporter A1 by Protecting It from Thiol Protease-mediated Degradation* , 2002, The Journal of Biological Chemistry.
[16] M. Oda,et al. Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I. , 2002, Biochemistry.
[17] R. F. Hoyt,et al. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. Rigneault,et al. Specific Docking of Apolipoprotein A-I at the Cell Surface Requires a Functional ABCA1 Transporter* , 2001, The Journal of Biological Chemistry.
[19] H. Brewer,et al. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. , 2001, Biochemical and biophysical research communications.
[20] T. Forte,et al. Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity. , 2001, Biochemistry.
[21] A. Tall,et al. Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1* , 2000, The Journal of Biological Chemistry.
[22] C. Gabel,et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] T. Langmann,et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.
[24] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[25] K. Weisgraber,et al. Apolipoprotein-mediated Plasma Membrane Microsolubilization , 1999, The Journal of Biological Chemistry.
[26] T. Forte,et al. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells. , 1999, Journal of lipid research.
[27] G. Anantharamaiah,et al. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes. , 1998, Biochemistry.
[28] H. Brewer,et al. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[29] D. Sviridov,et al. Efflux of Cellular Cholesterol and Phospholipid to Apolipoprotein A-I Mutants* , 1996, The Journal of Biological Chemistry.
[30] G. Anantharamaiah,et al. Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[31] G. Francis,et al. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.
[32] C. Fielding,et al. Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.
[33] R. Lees,et al. Homozygous Tangier disease and cardiovascular disease. , 1994, Atherosclerosis.
[34] L. McLean,et al. Kinetics of the interaction of amphipathic α-helical peptides with phosphatidylcholines , 1993 .
[35] R. Epand,et al. Effect of end group blockage on the properties of a class A amphipathic helical peptide , 1993, Proteins.
[36] T. Forte,et al. Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. , 1993, Journal of lipid research.
[37] W. J. Johnson,et al. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. , 1992, Journal of lipid research.
[38] G. Anantharamaiah,et al. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. , 1992, Journal of lipid research.
[39] M. Phillips,et al. Cholesterol efflux from arterial wall cells , 1991 .
[40] S. Yokoyama,et al. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. , 1991, The Journal of biological chemistry.
[41] P. D. Henry. Atherogenesis, calcium and calcium antagonists. , 1990, The American journal of cardiology.
[42] B. Rifkind. High-density lipoprotein cholesterol and coronary artery disease: survey of the evidence. , 1990, The American journal of cardiology.
[43] D. Eisenberg. Three-dimensional structure of membrane and surface proteins. , 1984, Annual review of biochemistry.
[44] David Eisenberg,et al. The helical hydrophobic moment: a measure of the amphiphilicity of a helix , 1982, Nature.
[45] H. Brewer,et al. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). , 1980, Annals of internal medicine.
[46] M C Hjortland,et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.
[47] O. Stein,et al. The removal of cholesterol from Landschütz ascites cells by high-density apolipoprotein. , 1973, Biochimica et biophysica acta.